Platelet-activating factor modulates phospholipid acylation in human neutrophils

Area of Science:

• Biochemistry
• Cell Biology
• Immunology

Background:

• Platelet-activating factor (PAF) is a potent lipid mediator involved in inflammation and immune responses.
• Phospholipid metabolism, particularly the incorporation of fatty acids, plays a critical role in cellular signaling and membrane dynamics.

Purpose of the Study:

• To investigate the effect of PAF on the rapid incorporation of arachidonate and docosahexaenoate into specific phospholipids in human neutrophils.
• To elucidate the role of extracellular calcium and the origin of newly formed phospholipids during PAF stimulation.

Main Methods:

• Human neutrophils were incubated with radiolabeled [1-14C]arachidonate and [1-14C]docosahexaenoate in the presence or absence of PAF.
• Analysis of phospholipid incorporation and formation was performed using liquid scintillation counting and chromatographic techniques.
• Experiments were conducted with and without extracellular calcium to assess its necessity.

Main Results:

• PAF rapidly stimulated the incorporation of both arachidonate and docosahexaenoate into phosphatidylinositol (PI) and phosphatidylcholine (PC) within 15 seconds.
• PAF inhibited the formation of labeled phosphatidic acid and did not alter the distribution of arachidonate in PC molecular species.
• The effect of PAF was concentration-dependent, with maximal stimulation at 10(-7) M, and was independent of extracellular calcium.

Conclusions:

• PAF acutely modulates phospholipid metabolism in neutrophils by enhancing fatty acid incorporation into PI and PC.
• The observed stimulation is likely secondary to increased deacylation of phospholipids, highlighting the specificity of acyltransferases.
• These findings provide insights into the early biochemical events triggered by PAF in neutrophils, relevant to inflammatory processes.